Belgium
Netherlands

A. Menarini Diagnostics and Nucleix announce a strategic partnership for a non-invasive bladder cancer test in Europe

Florence, Italy, 9 September 2024 - A. Menarini Diagnostics, a company bringing advanced solutions to the in vitro diagnostic market, and Nucleix, a liquid biopsy company revolutionizing cancer treatment by detecting the disease earlier, announced at the 36th European Congress of Pathology in Florence, that they have entered into a long-term commercial agreement for the exclusive distribution of the Bladder EpiCheck® test in Europe. 

36th European Congress of Pathology (ECP)

Florence, 7 -11 September 2024

14TH INTERNATIONAL CONGRESS ON AUTOIMMUNITY

Ljubljana, Slovenia, 17 -20 May, 2024

ECCMID 2024

European Congress of Clinical Microbiology and Infectious Diseases

Barcelona, 27 - 30 April 2024

booth D17

POINT-OF-CARE TESTING: STATE-OF-THE ART AND PERSPECTIVES

Venice, 4-5 April 2024

12345678

Our Values

4 values, which have given life to Menarini and shaped its history

READ MORE »